Stock News & Analysis

Investors should pay a premium for Joby but avoid Archer.

As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners.

Exercise of options at $25.29 per share followed by immediate open-market sale at $148.02, executed under a pre-established Rule 10b5-1 trading plan.

The provider of a cloud-based customer engagement platform reported a notable insider sale.

Valuation matters.

Management's commentary is putting the wind in investors' sails.

Warsh wants change, but inflation still dictates Fed policy.

Waller said he would consider leaving interest rates unchanged at the Fed's September meeting if the next inflation report shows progress toward the Fed's 2% target.

Markets push upwards as the likelihood of a September rate hike slips slightly, today, Sept. 3, 2026.

The robotaxi rollout is progressing better than headline numbers suggest, but uncertainty remains, and the bull-and-bear debate won't be resolved anytime soon.

With varying approaches to growing their businesses, both companies have something different to offer investors.

The medical device maker is on the cusp of a multi-year recovery.

Non-discretionary withholding tied to restricted stock unit settlement. CEO retains ~101,000 shares worth $25.41 million.

Even Social Security's richest beneficiaries may get a smaller boost than you expect.

Crain's purchase is a bullish signal for shareholders, with the executive now owning approximately $1.3 million worth of Core Scientific stock.

Booking Holdings' total yield, incorporating share buybacks, tops 7% -- and the stock is worth a closer look now.

Yields continue to rise despite Treasury's actions to push them lower.

The cloud-based data storage and analysis specialist got a lift from artificial intelligence (AI), delivering accelerating growth and a classic "beat and raise."

Investors need to start thinking about what's next in 2027.

Both have achieved profitability with similar leverage, but their margin profiles and valuations diverge sharply, one trades at a premium on pricing power, the other on scale.